Wealth Enhancement Advisory Services, LLC Halozyme Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 14,171 shares of HALO stock, worth $801,795. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,171
Previous 20,820
31.94%
Holding current value
$801,795
Previous $1.33 Million
44.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$997 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$726 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$342 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$220 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$208 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.88B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...